Abstract:Human APOBEC3 enzymes are a family of single-stranded (ss)DNA and RNA cytidine deaminases that act as part of the intrinsic immunity against viruses and retroelements. These enzymes deaminate cytosine to form uracil which can functionally inactivate or cause degradation of viral or retroelement genomes. In addition, APOBEC3s have deamination independent antiviral activity through protein and nucleic acid interactions. If expression levels are misregulated, some APOBEC3 enzymes can access the human genome leading to deamination and mutagenesis, contributing to cancer initiation and evolution. While APOBEC3 enzymes are known to interact with large ribonucleoprotein complexes, the function and RNA dependence is not entirely understood. To further understand their cellular roles, we determined by affinity purification mass spectrometry (AP-MS) the protein interaction network for the human APOBEC3 enzymes and map a diverse set of protein-protein and protein-RNA mediated interactions. Our analysis identified novel RNA-mediated interactions between APOBEC3C, APOBEC3H Haplotype I and II, and APOBEC3G with spliceosome proteins, and APOBEC3G and APOBEC3H Haplotype I with proteins involved in tRNA methylation and ncRNA export from the nucleus. In addition, we identified RNA-independent protein-protein interactions with APOBEC3B, APOBEC3D, and APOBEC3F and the prefoldin family of protein folding chaperones. Interaction between prefoldin 5 (PFD5) and APOBEC3B disrupted the ability of PFD5 to induce degradation of the oncogene cMyc, implicating the APOBEC3B protein interaction network in cancer. Altogether, the results uncover novel functions and interactions of the APOBEC3 family and suggest they may have fundamental roles in cellular RNA biology, their protein-protein interactions are not redundant, and there are protein-protein interactions with tumor suppressors, suggesting a role in cancer biology.

APOBEC3A can activate the DNA damage response and cause cell‐cycle arrest

APOBEC3 proteins and genomic stability

APOBEC3A damages the cellular genome during DNA replication

APOBEC3C, a nucleolar protein induced by genotoxins, is excluded from DNA damage sites

The DNA damage induced by the Cytosine Deaminase APOBEC3A Leads to the production of ROS

Protein interaction map of APOBEC3 enzyme family reveals deamination-independent role in cellular function

The spectrum of APOBEC3 activity: From anti-viral agents to anti-cancer opportunities

The APOBEC3 Family of Retroelement Restriction Factors

Role of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer

APOBEC3G rescues cells from the deleterious effects of DNA damage

Interaction with the CCT chaperonin complex limits APOBEC3A cytidine deaminase cytotoxicity

Regulation, functional impact, and therapeutic targeting of APOBEC3A in cancer

APOBEC3 genes: retroviral restriction factors to cancer drivers

Mechanisms of APOBEC3 mutagenesis in human cancer cells

APOBEC3s: DNA‐editing human cytidine deaminases

APOBEC3A induces DNA gaps through PRIMPOL and confers gap-associated therapeutic vulnerability

APOBEC3B reporter myeloma cell lines identify DNA damage response pathways leading to APOBEC3B expression

Self-cytoplasmic DNA upregulates the mutator enzyme APOBEC3A leading to chromosomal DNA damage

Competition for DNA binding between the genome protector replication protein A and the genome modifying APOBEC3 single-stranded DNA deaminases

The cytidine deaminase APOBEC3C has unique sequence and genome feature preferences